Cargando…
Ubiquitin-proteasome system-based signature to predict the prognosis and drug sensitivity of hepatocellular carcinoma
Background: Ubiquitin-proteasome system (UPS) is implicated in cancer occurrence and progression. Targeting UPS is emerging as a promising therapeutic target for cancer treatment. Nevertheless, the clinical significance of UPS in hepatocellular carcinoma (HCC) has not been entirely elucidated. Metho...
Autores principales: | Zhang, Jianxiang, Liu, Liwen, Wang, Zenghan, Hou, Mingyang, Dong, Zihui, Yu, Jia, Sun, Ranran, Cui, Guangying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166894/ https://www.ncbi.nlm.nih.gov/pubmed/37180696 http://dx.doi.org/10.3389/fphar.2023.1172908 |
Ejemplares similares
-
An anoikis-based signature for predicting prognosis in hepatocellular carcinoma with machine learning
por: Guizhen, Zhang, et al.
Publicado: (2023) -
A ubiquitin-related gene signature for predicting prognosis and constructing molecular subtypes in osteosarcoma
por: Wei, Nan, et al.
Publicado: (2022) -
A Ubiquitin-Proteasome Gene Signature for Predicting Prognosis in Patients With Lung Adenocarcinoma
por: Tang, Yunliang, et al.
Publicado: (2022) -
Ubiquitin-Proteasome-Collagen (CUP) Pathway in Preterm Premature Rupture of Fetal Membranes
por: Zhao, Xinliang, et al.
Publicado: (2017) -
An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
por: Zhang, Zhenyu, et al.
Publicado: (2022)